Zydus Lifesciences acquires 50% stake in Sterling Biotech

Zydus Lifesciences entered a joint venture with Perfect Day by acquiring a 50% stake in Sterling Biotech. The collaboration aims to build a manufacturing facility for animal-free protein products, addressing global demand. This venture marks Zydus' entry into the biotech sector, focusing on health and nutrition solutions for lactose-intolerant consumers and those preferring animal-free options.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KLn5ITj
via IFTTT